Company / Named in our posts
Tourmaline Bio, Inc..
Follow Tourmaline Bio, Inc.A late-stage clinical biotechnology company developing medicines for patients with life-altering immune diseases.[1]
02Deals
Deals on Carrywatch
Every deal that names Tourmaline Bio, Inc., and its role in each.
Novartis / Tourmaline Bio, Inc.
Novartis completes Tourmaline Bio acquisition
See deal detailsTalaris Therapeutics, Inc. / Tourmaline Bio, Inc.
Talaris Therapeutics, Inc. agrees to buy Tourmaline Bio, Inc.
See deal detailsDeal Web
Tourmaline Bio, Inc. and 2 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as Tourmaline Bio, Inc. reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
Company disclosure · Researched 24 Oct 2026
- 02SEC EDGAR company record for Tourmaline Bio, Inc.
Company disclosure · Researched 24 Oct 2026
Deal posts naming Tourmaline Bio, Inc.:
- P01Novartis AG: Novartis / Tourmaline Bio, Inc.
28 Oct 2025
- P02